Linkinvax Europe
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Linkinvax Europe - overview
Established
2020
Location
Paris, -, France
Primary Industry
Biotechnology
About
Based in Paris, France, and founded in 2020 by its CEO, Dr. Auberton-Hervé André-Jacques, and co-founders Gaston-Dreyfus Rémi, and Pr. Yves Lévy, Linkinvax Europe operates as a clinical-stage biotechnology company that specializes in the research and development of prophylactic and therapeutic vaccines. In January 2023, Linkinvax Europe raised EUR 50 million in series A funding from In-Q-Tel, with participation from the company's management.
Linkinvax Europe offers a protein-based vaccine platform that addresses multiple pathogens with adaptability to mutations, including viral or bacterial infectious diseases and cancer treatments. Its product portfolio encompasses a wide range of dendritic cell-based vaccines, both preventive and therapeutic, such as the COVID-19 vaccine, developed to address multi-epitopes and variants, as well as the pandemic caused by the SARS-CoV-2 virus; the HIV vaccine; and the HPV-linked cancer vaccine. The company plans to use the Series A funding to accelerate the clinical development of its protein-based vaccine platform.
Current Investors
In-Q-Tel
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment
Website
www.linkinvax.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.